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Abstract  
Common genetic risk variants have been implicated in the etiology of clinical ADHD diagnoses 
and symptoms in the general population. However, given the extensive comorbidity across ADHD 
and other psychiatric conditions, the extent to which genetic variants associated with ADHD also 
influence broader psychopathology dimensions remains unclear. The aim of this study was to 
evaluate the associations between ADHD polygenic risk scores (PRS) and a broad range of 
childhood psychiatric problems, and to quantify the extent to which such associations can be 
attributed to a general factor of childhood psychopathology. We derived ADHD PRS for 13,457 
children aged 9 or 12 from the Child and Adolescent Twin Study in Sweden, using results from an 
independent meta-analysis of genome-wide association studies of ADHD diagnosis and symptoms. 
We estimated associations between ADHD PRS, a general psychopathology factor, and several 
dimensions of neurodevelopmental, externalizing and internalizing symptoms, using structural 
equation modelling. Higher ADHD PRS were statistically significantly associated with elevated 
neurodevelopmental, externalizing and depressive symptoms (R2=0.26%-1.69%), but not with 
anxiety. After accounting for a general psychopathology factor, on which all symptoms loaded 
positively (mean loading=0.50, range=0.09-0.91), an association with specific 
hyperactivity/impulsivity remained significant. ADHD PRS explained ~1% (p-value<0.0001) of 
the variance in the general psychopathology factor and ~0.50% (p-value<0.0001) in specific 
hyperactivity/impulsivity. Our results suggest that common genetic risk variants associated with 
ADHD, and captured by PRS, also influence a general genetic liability towards broad childhood 
psychopathology in the general population, in addition to a specific association with 
hyperactivity/impulsivity symptoms. 
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Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is common neurodevelopmental disorder that 
affects 5-10% of children and is characterized by excessive inattentive and hyperactive/impulsive 
symptoms.1 It is well-established that genetic factors contribute to ADHD liability; twin and sibling 
studies consistently estimate the heritability of ADHD at 70-80%.2-7 More recently, the largest 
GWAS of clinical ADHD to date identified the first genome-wide significant loci associated with 
ADHD, and estimated the proportion of phenotypic variance explained by measured single 
nucleotide polymorphisms (SNPs) at 22% (standard error [SE]=0.01).8 Significant SNP-heritability 
has also been reported by the largest GWAS of ADHD symptoms in population-based samples 
(5%[SE=0.06] to 34%[SE=0.17]),9 with a near complete sharing of genetic risks reported across 
these different ADHD definitions (rg=0.94[SE=0.20]).8  
In addition to evidence of a strong genetic liability, it is well known that ADHD is highly comorbid 
with other psychiatric conditions.10 One important question is therefore the degree to which genetic 
risk implicated in ADHD is disorder-specific. Findings from population-based twin studies have 
reported moderate to strong genetic correlations between ADHD and other childhood psychiatric 
conditions, including autistic traits (rg range 0.54-0.87),11 learning disabilities (rg range 0.31-
0.41),12-14 oppositional defiant and conduct problems (rg range 0.46-0.74),15-17 anxiety (rg range 
0.45-0.58), and depression (rg range 0.34-0.77).11 Molecular genetic studies also support a genetic 
overlap between ADHD and a broad range of psychiatric conditions. For example, ADHD 
polygenic risk scores (i.e., weighted sum scores of an individual’s estimated total burden of risk 
alleles associated with a phenotype [PRS])18 have been associated with lower educational 
attainment, cognition, and conduct problems.8,19-22 Mixed findings have been reported for ADHD 
PRS and associations with autism and depression.23-28  
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Based on the extensive phenotypic and genetic overlap among psychiatric disorders, it has been 
suggested that comorbidity may be attributed to a general factor of psychopathology that increases 
risk for virtually all prevalent psychiatric conditions.29,30 Twin and sibling studies have shown that 
a latent shared genetic factor can account for on average 45% of variance in childhood 
externalizing, internalizing, and phobia symptoms,29,31 31% of variance in childhood 
neurodevelopmental symptoms,32 and 22% of disorder liability in several clinical psychiatric 
diagnoses, including ADHD.33 The twin-based heritability of such a general psychopathology 
factor has been estimated at 43% in one study31 and the SNP-heritability to 18%(SE=0.10)34 and 
38%(SE=0.16)35 in two separate population-based pediatric samples.  
These findings suggest that the co-occurrence of childhood psychiatric conditions is, at least in 
part, due to shared common risk variants. Given the extensive comorbidity in ADHD and shared 
genetic risks with other psychopathology, it can thus be hypothesized that a proportion of the 
genetic risk variants associated with ADHD in recent GWAS8 might not be disorder-specific, but 
rather act to increase risk for general childhood psychopathology more broadly. However, we are 
not aware of any studies addressing this question using molecular genetic data. The aims of the 
current study were therefore to: 1) examine whether ADHD PRS are associated with a range of 
neurodevelopmental, externalizing and internalizing symptom dimensions in a large general 
population sample, and 2) quantify the extent to which any observed associations between ADHD 
PRS and the aforementioned symptom dimensions can be attributed to a general childhood 
psychopathology factor. 
Methods 
Study population  
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The Child and Adolescent Twin Study in Sweden (CATSS) is an ongoing study targeting all 9-
year-old (born after June 1995) and 12-year-old (born before July 1995) twins born in Sweden 
since July 1992. Parents were contacted for a telephone interview on the twins’ 9th or 12th birthdays. 
The overall response rate in CATSS is 80%. Analyses comparing non-responders and responders 
have shown that participating families generally have higher socio-economic status, lower rates of 
parental psychiatry illness and child clinical diagnosis for ADHD, ASD and learning disabilities.36 
CATSS was approved by the ethics committee at Karolinska Institutet and all participants gave 
informed consent. The study has been described in detail elsewhere.36 
Genotyping and imputation  
A total of 11,551 CATSS twins were genotyped using the Illumina Infinium PsychArray-24 
BeadChip. Prior to analysis, stringent quality control (QC) procedures were performed on the 
genotyped markers and individuals using standardized procedures. After QC, 561,187 genotyped 
SNPs and 11,081 samples were retained. Genotypes for another 2,495 MZ twins were imputed 
from their genotyped co-twin, resulting in a sample size of 13,576 samples with genotype data. 
Details of the QC protocol, imputation, and principal components (PC) extraction are presented in 
supplementary note 1 and Figure S1. CATSS participants without available genetic data differed 
to those included in the current sample, in that they showed higher levels of ADHD symptoms and 
diagnoses, were more likely to be male, and have parents with lower education levels (see 
supplementary Table S1). 
Polygenic risk scores 
Polygenic risk scores (PRS) were generated in CATSS based on summary statistics from what 
should theoretically be the most powerful discovery sample available to derive ADHD PRS: a 
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meta-analysis of the largest GWAS of clinically diagnosed ADHD (20,183 cases, 35,191 controls)8 
and the largest GWAS of ADHD symptoms (17,666 children from population-based samples). 
Details of the discovery sample are provided in supplementary note 2.9 We calculated standardized 
betas for each SNP, based on available z-scores, effective sample size and allele frequency in the 
discovery GWAS.37 After excluding individuals with parent-reported cerebral palsy, Down 
syndrome, brain injury and chromosomal abnormalities (supplementary Figure S1), ADHD PRS 
were derived in CATSS from best-guess imputed genotypes across a range of p-value thresholds 
(0.00001≤PT ≤1). Indels, multi-allelic and symmetric/ambiguous SNPs were excluded. Autosomal 
SNPs with a minor allele frequency (MAF)≥0.05 and good imputation quality (INFO score)≥0.8 
were clumped (linkage disequilibrium threshold R2 > 0.1,±1000 kb) using PLINK.v.1.9.38 Retained 
reference alleles were scored across the set of SNPs in PLINK (applying the command --score no-
mean-imputation) using standard procedures.39,40 In line with previous publications, we used the 
PRS including SNPs at a threshold of PT ≤0.50 for the main analysis.20,41 Sensitivity analyses of 
PRS associations across other p-value thresholds are presented in the supplementary materials. 
Childhood psychiatric symptoms 
Childhood psychiatric symptoms were assessed using the Autism-Tics, ADHD, and Other 
Comorbidities inventory (A-TAC). A-TAC is a 96 items questionnaire corresponding to DSM-IV 
definitions of childhood psychiatric disorders. Questions assess lifetime symptoms in relation to 
same-age peers.42 We selected the 62 symptoms items measuring inattention (IA), 
hyperactivity/impulsivity (H/I), autism spectrum disorder (ASD), learning difficulties (LD), 
oppositional defiant disorder (ODD), conduct disorder (CD), depression (DEP) and anxiety 
(ANX). A-TAC has been validated, with neurodevelopmental and externalizing scales showing 
strong internal consistency and moderate to strong predictive validity.42-45 A-TAC anxiety and 
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depression items have not been validated and were only assessed in twins born 1992-1997. For 
twins born after 1997, depression symptoms were instead assessed using the Short Mood and 
Feelings Questionnaire (SMFQ), a 13-item questionnaire measuring child depressive symptoms 
experienced in the last two weeks.46 Anxiety symptoms were assessed using the Screen for Child 
Anxiety Related Emotional Disorders (SCARED), a 41-item questionnaire measuring symptoms 
experienced in the last three months across five anxiety dimensions: panic disorder (PD), 
generalized anxiety disorder (GAD), separation anxiety disorder (SAD), school anxiety (SA) and 
social phobia (SP).47 SMFQ and SCARED are validated questionnaires, with strong internal 
consistency and moderate predictive validity for clinical diagnoses.47-51 
All scales were rated according to three response categories: “no” (coded 0), “yes, to some extent” 
(coded 1), and “yes” (coded 2). As the A-TAC internalizing scales, SCARED and SMFQ are not 
directly comparable measures, we used a split-sample approach based on the available internalizing 
assessments. The final sample sizes with genotype and phenotype data were 6603 (3483 unrelated 
individuals) for the A-TAC subsample, and 6854 (3634 unrelated individuals) in the 
SMFQ/SCARED subsample. Based on previous simulation studies, this sample size is more than 
adequate for estimating complex structural equation models (SEM) and PRS associations.52,53  
Statistical Analyses  
We estimated associations between ADHD PRS and ADHD symptom dimensions (IA, H/I) and 
related neurodevelopmental (ASD, LD), externalizing (ODD, CD), and internalizing symptom 
dimensions (DEP, ANX), using confirmatory factor analysis (CFA) implemented via SEM. Path 
diagrams of the models are presented by subsample in Figure 1.  
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We first fitted a correlated factors model where symptoms from each subscale were set to load onto 
a corresponding single latent trait factor. All the latent factors were allowed to correlate. In the A-
TAC subsample, a correlated factors model with eight latent factors was fitted, corresponding to 
symptoms dimensions of IA, H/I, ASD, LD, ODD, CD, DEP and ANX. In the SMFQ/SCARED 
subsample, we fitted a 12 correlated factors model, including the first six factors outlined above, 
one DEP factor measured via SMFQ, and five latent anxiety factors corresponding to the SCARED 
subscales of PD, GAD, SAD, SP, and SA. Previous studies of the SCARED have shown that this 
five-factor structure has the best psychometric properties for the questionaire.54-56 
Second, we fitted a bifactor (or general factor) model, which in addition to the latent trait factors, 
included a general psychopathology factor. The general factor model quantifies the extent to which 
covariance among symptom dimensions reflects both a general factor (on which all assessed 
symptoms load), and a number of specific latent factors (on which only a subset of the symptoms 
load).57,58 Correlations between the specific latent trait factors and the general factor are fixed at 
zero, whereas correlations between the specific latent factors are free to vary. 
>>>>>>>>>>>>>>>>Figure 1<<<<<<<<<<<<<<<<<<< 
In both models, the latent factors were regressed on ADHD PRS using SEM, with sex, age and the 
first six PCs (to account for population stratification) included as covariates. We evaluated if the 
models provided a good fit to the underlying data using the comparative fit index (CFI), and the 
root mean square error of approximation (RMSEA).59  A likelihood ratio test was used to test 
whether the exclusion of the general factor from the correlated factor model led to a significant 
decrease in model fit. To account for the non-independence of twin data, family clusters were 
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specified and standard errors were estimated using a sandwich estimator. All models were run using 
Mplus.60  
Sensitivity Analyses 
We performed several sensitivity analyses to test the robustness of results from the general factor 
model (see supplementary note 3 for details). First, to test whether observed associations were 
driven by ADHD cases, we re-ran analyses excluding children with an ADHD diagnosis (ICD 
and/or >=8 A-TAC DSM-based symptoms). For completeness, we present the number children 
with an ICD diagnosis corresponding to the any of the assessed symptoms dimensions in 
supplementary Table S2. Second, we excluded one twin in every monozygotic (MZ) pair to confirm 
that estimates were not inflated by the inclusion of genetically identical individuals. Third, we 
tested for sex differences in the association between ADHD PRS and the latent factors. Finally, we 
tested whether ADHD PRS showed similar associations with the latent factors across a range of 
seven p-value thresholds (0.00001≤PT≤1).  
Code availability 
Computer codes are available upon request from the corresponding author. 
Results  
Correlated Factor Model  
The correlated factor model fit the data well in both subsamples (CFI>0.94 and RMSEA<0.02)59 
(Table 1). All symptoms loaded positively and significantly onto their corresponding latent trait 
factor. Standardized factor loadings are reported in Table 2. Neurodevelopmental, externalizing, 
and internalizing latent factors were moderately to strongly correlated in the A-TAC subsample 
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(mean r=0.64, range=0.44-0.83). Similar correlations were found in the SMFQ/SCARED 
subsample across neurodevelopmental, externalizing and the depression latent factors (mean 
r=0.62, range=0.40-0.84), whereas correlations with the latent anxiety factors were generally 
weaker (mean r=0.40, range=0.11-0.65). Notably, social phobia showed a particularly weak 
correlation with hyperactivity/impulsivity (r=0.11), and overall lower correlations with all latent 
factors (mean r=0.33, range=0.11-0.52). Correlations from all models, before and after regression 
of PRS and covariates, are presented in supplementary Figures S2-S3.  
In both subsamples, higher ADHD PRS were statistically significantly associated with higher 
symptom levels in all latent neurodevelopment, externalizing and depression factors, after 
adjusting for covariates. ADHD PRS was not statistically significantly associated with any of the 
latent anxiety factors, with the exception of the latent PD factor (β=0.06, p=0.011). Standardized 
regression results for PRS p-value threshold≤0.5 are reported in Table 3, and results across p-value 
thresholds in supplementary Figures S4-S5. 
General Factor Model  
The general factor model also fit the data well in both subsamples (CFI>0.96, RMSEA<0.02). 
Furthermore, omitting the general psychopathology factor resulted in a statistically significant 
decrease in model fit (Table 1). Standardized factor loadings are presented in Table 2. In both 
subsamples, all symptoms loaded positively and significantly onto the general psychopathology 
factor. Mean loadings were strongest for neurodevelopmental traits (A-TAC subsample mean 
loading=0.64, range=0.39-0.91: SMFQ/SCARED subsample mean loading=0.64, range=0.40-
0.91), slightly lower for externalizing traits (A-TAC subsample mean loading=0.51, range=0.32-
0.60: SMFQ/SCARED subsample mean loading=0.49, range=0.32-0.62) and weakest for 
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internalizing traits (A-TAC subsample mean loading=0.41, range=0.24-0.61: SMFQ/SCARED 
subsample mean loading=0.32, range=0.09-0.66). The general psychopathology factor explained 
56% of the covariance across traits (explained common variance [ECV]) in the A-TAC subsample 
and 40% in the SMFQ/SCARED subsample.61 Correlations across the latent specific factors were 
attenuated in the general factor model. Notably, correlations between LD and all other factors were 
attenuated towards the null or showed an inverse association. Further, SP became significantly 
negatively correlated with IA and H/I (supplementary Figures S2-S3).   
In both subsamples, higher ADHD PRS were significantly associated with the general 
psychopathology factor (β=0.09-0.10, p<0.0001), explaining~1% after adjusting for covariates. 
After accounting for covariance across all symptoms via the general psychopathology factor, the 
association between ADHD PRS and the specific latent H/I factor remained significant in both 
subsamples (β=0.06-0.08, p<0.0001), explaining 0.37-0.69% after adjusting for covariates. In the 
SMFQ/SCARED subsample, we also observed a significant negative association between ADHD 
PRS and the specific latent SP factor (β=-0.05, p=0.004). Standardized regression results for 
ADHD PRS p-value threshold≤0.5 are reported in Table 3, and across other p-value thresholds in 
supplementary figures S4-S5. 
Sensitivity Analyses 
After excluding ADHD cases, ADHD PRS remained statistically significantly associated with the 
general psychopathology factor and the specific H/I factor in both subsamples. Results excluding 
one MZ twin per pair did not differ markedly from the main analyses. Analyses testing for sex 
differences in the association between ADHD PRS and the latent factors showed a similar pattern 
of results as the main analyses, although PRS associations were generally stronger in males 
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(general factor R2=1.00-1.14%: H/I R2=0.81%), than in females (general factor R2=0.36-0.81%: 
H/I R2=0.03-1.00%). 
Discussion  
Results from this study show that common GWAS variants that increase the risk for ADHD as 
captured by PRS, are not only associated with ADHD symptoms (R2=0.83%-1.69%) in an 
independent population-based sample, but also with a range of childhood neurodevelopmental 
(R2=0.40%-0.53%), externalizing (R2=0.41%-1.19%), and to a lesser extent, internalizing 
symptoms (R2=0%-0.41%). Importantly, when modelling the shared variance across these 
symptom dimensions, we found that the associations were largely accounted for by a general 
childhood psychopathology factor. The significant association between ADHD PRS and a general 
psychopathology factor (R2=0.86%-1.06%) suggests that a considerable portion of the genetic 
variants associated with ADHD, that are captured by PRS and shared with other measures, reflect 
a non-specific genetic liability towards broad childhood psychopathology.  
Beyond the association between ADHD PRS and a general psychopathology factor, results also 
showed a unique association for ADHD PRS with specific hyperactivity/impulsivity (R2=0.37%-
0.69%). About 2/3 of the association between ADHD PRS and hyperactivity/impulsivity could be 
attributed to general variance shared across childhood psychopathology symptoms, and about 1/3 
to variance specific to hyperactivity/impulsivity. These finding were robust across both subsamples 
and provide important molecular genetic confirmation of results from previous twin studies, 
showing that a substantial proportion of genetic influences on ADHD symptoms are shared with a 
general psychopathology factor, but there also ADHD-specific genetic influences.29,32,33 
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In contrast, there was no significant association between ADHD PRS and specific inattention. 
There are several potential reasons for the differential pattern of ADHD PRS association across 
ADHD symptom dimensions; it is possible that hyperactive/impulsive symptoms are stronger 
drivers of ADHD diagnosis, leading to an overrepresentation of combined and primarily 
hyperactive/impulsive ADHD cases in the clinical discovery GWAS. The lack of association 
between ADHD PRS and specific inattention problems is likely also explained  by the fact that the 
majority of the inattentive symptoms loaded very strongly onto the general psychopathology factor, 
leaving little variance in the specific inattention factor. This may suggest that inattention is 
phenotypically and genetically more closely linked to a general liability for childhood 
psychopathology, or it may reflect measurement properties of the A-TAC. To disentangle these 
explanations, results would need to be replicated in a different sample using other measures and/or 
raters. 
In the correlated factors model, we found significant ADHD PRS associations with 
neurodevelopmental, externalizing, and depression symptom dimensions, but not with anxiety. 
Anxiety symptoms also showed the weakest loadings onto a general factor, both when measured 
by A-TAC and SCARED. These results suggest that anxiety may be less genetically associated 
with ADHD in childhood, as compared to other psychopathology dimensions. Such a conclusion 
is generally consistent with findings from twin and molecular studies.11 Nonetheless, it is also 
possible that parent-ratings do not fully capture variation in child anxiety symptoms at this age,51 
which may in part explain the observed overall weaker associations seen for anxiety. Somewhat 
surprisingly, we observed a significant negative association between ADHD PRS and specific 
social phobia in the general factor model in the SMFQ/SCARED subsample. Social phobia was 
also the only latent anxiety factor to show a significant negative association with ADHD symptoms 
14 
 
in the general factor model. This suggests that the negative association between ADHD PRS and 
social phobia may reflect the previously reported tendency for internalizing and externalizing 
symptom dimensions to become inversely associated in general factor models.30,62,63   
Analyses stratified by sex generally showed stronger PRS associations in males relative to females, 
particularly for the associations with the general psychopathology factor and specific 
hyperactivity/impulsivity. Whilst this could reflect sex-specific genetic differences, it is more 
likely to be explained by lower levels of hyperactivity/impulsivity, neurodevelopmental, and 
externalizing problems in females.64 
Finally, by demonstrating that PRS derived from a GWAS meta-analysis of clinically diagnosed 
and population trait ADHD are also linked to a wide range of childhood psychopathology problems 
in the general population, this study further highlights the utility of recently developed multivariate 
GWAS methods.65-67 Possibilities for joint analysis of GWAS data across psychiatric conditions, 
and across clinical and population samples, are important not only to boost power, but also to 
identify genetic factors which influence broader psychopathology dimensions.57 
Limitations 
Results from this study must be interpreted in the context of the study limitations. First, we relied 
on parent ratings of childhood psychiatric symptoms, which may inflate cross-trait covariance and 
possibly lead to overestimation of the general psychopathology factor.62 Although we cannot 
exclude this possibility, loadings and variance explained by the general factor in this study was 
generally in line with previous findings using multiple raters62 or register-based clinical 
diagnoses.33 Second, the current study is cross-sectional. Although there is strong evidence for 
genetic stability in ADHD,23,68 the phenotypic expression of psychiatric symptoms changes across 
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development, meaning that the pattern and strength of ADHD PRS associations may also differ 
with age.23,41 Third, families who participated in CATSS generally had lower rates of psychiatric 
disorder compared to non-responders.36 Further, the current study sample had significantly lower 
rates of ADHD compared to CATSS participants who did not provide genotype data 
(supplementary Table S2). It is therefore likely that children with higher levels of psychopathology 
and genetic load for ADHD were underrepresented in this study, which may have attenuated the 
estimated associations. Fourth, the trait variance explained by PRS is generally small; in the recent 
clinical ADHD GWAS, ADHD PRS accounted for only about 5.5% of the variance in case-control 
ADHD status.8 Genetic cross-disorder overlap identified in secondary PRS studies is typically even 
smaller (< 1% variance explained), and this study is no exception. Thus, our findings very likely 
do not reflect the total genetic overlap between ADHD and related childhood psychopathology. As 
the predictive utility of PRS are largely a function of the power of GWAS discovery samples from 
which the scores were derived, association testing with PRS and comparison of results across PRS 
studies will likely improve as GWAS discovery sample sizes increase.40,53 Such developments have 
been seen for schizophrenia and in other areas of medicine.53,69 Finally, PRS analyses do not 
distinguish the specific genetic loci driving the PRS-trait associations. We were therefore unable 
to separate genetic variants underpinning the association with specific hyperactivity/impulsivity, 
from those associated with a general liability towards childhood psychopathology. 
Conclusion 
Results from this study indicate that genetic risk variants associated with ADHD captured by PRS 
also influence a more a general genetic liability towards broad childhood psychopathology. Beyond 
contributing to shared genetic liability, ADHD PRS also seem to capture genetic risk with stronger 
and/or unique effects on hyperactivity/impulsivity. Our findings emphasize the utility of adopting 
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a more dimensional, multivariate framework, and the need to account for the inter-related nature 
of psychiatric conditions when studying the genetic architecture of childhood psychopathology.57 
  
17 
 
Supplementary information is available at MP’s website 
Acknowledgments 
We gratefully acknowledge the contribution of the participants in the Child and Adolescent Twin 
Study in Sweden (CATSS) and their families. CATSS is supported by the Swedish Council for 
Working Life (no 2012-1678 and 2014-0834), funds under the ALF agreement (no 2014-0322) and 
the Swedish Research Council (no 340-2013-5867 and 2014-3831). Dr. Martin was supported by 
the Wellcome Trust (Grant No: 106047). The funders had no role in study design, data collection 
and analysis, decision to publish or preparation of the manuscript. We also acknowledge and thank 
Dr Patrik Magnusson for his work and expertise on the genotyping, imputation and quality control 
process of the genetic samples in CATSS, and Dr Raymond Walters for his statistical advice and 
expertise on the use of the iPSYCH/PGC+EAGLE GWAS meta-analysis discovery data. 
Conflicts of Interest 
Ms. Brikell, Drs. Lu, Pettersson, Chen, Kuja-Halkola, Karlsson, Lahey, and Martin declare no 
potential conflicts of interest. Dr. Larsson has served as a speaker for Eli-Lilly and Shire and has 
received research grants from Shire. Dr. Lichtenstein has served as a speaker for Medice. All 
outside the submitted work. 
  
18 
 
References 
1. Polanczyk, G.V., Willcutt, E.G., Salum, G.A., Kieling, C. & Rohde, L.A. ADHD prevalence estimates 
across three decades: an updated systematic review and meta-regression analysis. International 
Journal of Epidemiology (2014). 
2. Brikell, I., Kuja-Halkola, R. & Larsson, H. Heritability of attention-deficit hyperactivity disorder in 
adults. Am J Med Genet B Neuropsychiatr Genet (2015). 
3. Larsson, H., Chang, Z., D'Onofrio, B.M. & Lichtenstein, P. The heritability of clinically diagnosed 
attention deficit hyperactivity disorder across the lifespan. Psychological Medicine 44, 2223-2229 
(2014). 
4. Nikolas, M.A. & Burt, S.A. Genetic and environmental influences on ADHD symptom dimensions 
of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol 119, 1-17 (2010). 
5. Faraone, S.V. et al. Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 
15020 (2015). 
6. Chen, Q. et al. Familial aggregation of attention-deficit/hyperactivity disorder. J Child Psychol 
Psychiatry (2016). 
7. Greven, C.U., Rijsdijk, F.V. & Plomin, R. A twin study of ADHD symptoms in early adolescence: 
hyperactivity-impulsivity and inattentiveness show substantial genetic overlap but also genetic 
specificity. J Abnorm Child Psychol 39, 265-75 (2011). 
8. Demontis, D. et al. Discovery Of The First Genome-Wide Significant Risk Loci For ADHD. bioRxiv 
(2017). 
9. Middeldorp, C.M. et al. A Genome-Wide Association Meta-Analysis of Attention-
Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. J Am Acad Child 
Adolesc Psychiatry 55, 896-905.e6 (2016). 
10. Jensen, C.M. & Steinhausen, H.-C. Comorbid mental disorders in children and adolescents with 
attention-deficit/hyperactivity disorder in a large nationwide study. ADHD Attention Deficit and 
Hyperactivity Disorders 7, 27-38 (2015). 
11. Martin, J., Taylor, M.J. & Lichtenstein, P. Assessing the evidence for shared genetic risks across 
psychiatric disorders and traits. Psychological Medicine, 1-16 (2017). 
12. Greven, C.U., Harlaar, N., Dale, P.S. & Plomin, R. Genetic Overlap between ADHD Symptoms and 
Reading is largely Driven by Inattentiveness rather than Hyperactivity-Impulsivity. J Can Acad 
Child Adolesc Psychiatry 20, 6-14 (2011). 
13. Greven, C.U., Kovas, Y., Willcutt, E.G., Petrill, S.A. & Plomin, R. Evidence for shared genetic risk 
between ADHD symptoms and reduced mathematics ability: a twin study. J Child Psychol 
Psychiatry 55, 39-48 (2014). 
14. Wadsworth, S.J., DeFries, J.C., Willcutt, E.G., Pennington, B.F. & Olson, R.K. The Colorado 
longitudinal twin study of reading difficulties and ADHD: Etiologies of comorbidity and stability. 
Twin Research and Human Genetics 18, 755-761 (2015). 
15. Dick, D.M., Viken, R.J., Kaprio, J., Pulkkinen, L. & Rose, R.J. Understanding the Covariation Among 
Childhood Externalizing Symptoms: Genetic and Environmental Influences on Conduct Disorder, 
Attention Deficit Hyperactivity Disorder, and Oppositional Defiant Disorder Symptoms. Journal of 
Abnormal Child Psychology 33, 219-229 (2005). 
16. Tuvblad, C., Zheng, M., Raine, A. & Baker, L.A. A common genetic factor explains the covariation 
among ADHD ODD and CD symptoms in 9–10 year old boys and girls. Journal of abnormal child 
psychology 37, 153-167 (2009). 
17. Kuja-Halkola, R., Lichtenstein, P., D'Onofrio, B.M. & Larsson, H. Codevelopment of ADHD and 
externalizing behavior from childhood to adulthood. J Child Psychol Psychiatry (2014). 
19 
 
18. Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar 
disorder. Nature 460, 748-52 (2009). 
19. Stergiakouli, E. et al. Association between polygenic risk scores for attention-deficit hyperactivity 
disorder and educational and cognitive outcomes in the general population. Int J Epidemiol 
(2016). 
20. Martin, J., Hamshere, M.L., Stergiakouli, E., O'Donovan, M.C. & Thapar, A. Neurocognitive 
abilities in the general population and composite genetic risk scores for attention-deficit 
hyperactivity disorder. J Child Psychol Psychiatry 56, 648-56 (2015). 
21. Du Rietz, E. et al. Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With 
Co-occurring Traits and Disorders. Biological Psychiatry: Cognitive Neuroscience and 
Neuroimaging (2017). 
22. Hamshere, M.L. et al. High loading of polygenic risk for ADHD in children with comorbid 
aggression. Am J Psychiatry 170, 909-16 (2013). 
23. Stergiakouli, E. et al. Shared genetic influences between dimensional ASD and ADHD symptoms 
during child and adolescent development. Molecular Autism 8, 18 (2017). 
24. MartiŶ, J., Haŵshere, M.L., Stergiakouli, E., O’DoŶoǀaŶ, M.C. & Thapar, A. GeŶetic risk for 
attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general 
population. Biol Psychiatry 76(2014). 
25. Bulik-Sullivan, B. et al. An Atlas of Genetic Correlations across Human Diseases and Traits, (2015). 
26. Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. bioRxiv (2016). 
27. Krapohl, E. et al. Phenome-wide analysis of genome-wide polygenic scores. Mol Psychiatry 21, 
1188-1193 (2016). 
28. Cross-Disorder Group of the Psychiatric Genomics, C. Identification of risk loci with shared 
effects on five major psychiatric disorders: a genome-wide analysis. The Lancet 381, 1371-1379 
(2013). 
29. Lahey, B.B., Van Hulle, C.A., Singh, A.L., Waldman, I.D. & Rathouz, P.J. Higher-order genetic and 
environmental structure of prevalent forms of child and adolescent psychopathology. Archives of 
General Psychiatry 68, 181-189 (2011). 
30. Caspi, A. et al. The p Factor: One General Psychopathology Factor in the Structure of Psychiatric 
Disorders? Clinical psychological science : a journal of the Association for Psychological Science 2, 
119-137 (2014). 
31. Waldman, I.D., Poore, H.E., van Hulle, C., Rathouz, P.J. & Lahey, B.B. External validity of a 
hierarchical dimensional model of child and adolescent psychopathology: Tests using 
confirmatory factor analyses and multivariate behavior genetic analyses. J Abnorm Psychol 125, 
1053-1066 (2016). 
32. Pettersson, E., Anckarsater, H., Gillberg, C. & Lichtenstein, P. Different neurodevelopmental 
symptoms have a common genetic etiology. J Child Psychol Psychiatry 54, 1356-65 (2013). 
33. Pettersson, E., Larsson, H. & Lichtenstein, P. Common psychiatric disorders share the same 
genetic origin: a multivariate sibling study of the Swedish population. Mol Psychiatry 21, 717-721 
(2016). 
34. Pappa, I. et al. Single Nucleotide Polymorphism Heritability of Behavior Problems in Childhood: 
Genome-Wide Complex Trait Analysis. J Am Acad Child Adolesc Psychiatry 54, 737-44 (2015). 
35. Neumann, A. et al. Single Nucleotide Polymorphism Heritability of a General Psychopathology 
Factor in Children. J Am Acad Child Adolesc Psychiatry 55, 1038-1045 e4 (2016). 
36. Anckarsater, H. et al. The Child and Adolescent Twin Study in Sweden (CATSS). Twin Res Hum 
Genet 14, 495-508 (2011). 
37. Rietveld, C.A. et al. GWAS of 126,559 individuals identifies genetic variants associated with 
educational attainment. Science 340, 1467-71 (2013). 
20 
 
38. Purcell, S. et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage 
Analyses. The American Journal of Human Genetics 81, 559-575 (2007). 
39. Consortium, C.-D.G.o.t.P.G. Identification of risk loci with shared effects on five major psychiatric 
disorders: a genome-wide analysis. Lancet 381, 1371 - 1379 (2013). 
40. Wray, N.R. et al. Research review: polygenic methods and their application to psychiatric traits. J 
Child Psychol Psychiatry 55(2014). 
41. Riglin, L., Collishaw, S., Thapar, A.K. & et al. Association of genetic risk variants with attention-
deficit/hyperactivity disorder trajectories in the general population. JAMA Psychiatry 73, 1285-
1292 (2016). 
42. Larson, T. et al. The Autism - Tics, AD/HD and other Comorbidities inventory (A-TAC): further 
validation of a telephone interview for epidemiological research. BMC Psychiatry 10, 1 (2010). 
43. Hansson, S.L. et al. Psychiatric telephone interview with parents for screening of childhood 
autism-tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary 
reliability and validity. Br J Psychiatry 187(2005). 
44. Larson, T. et al. Predictive properties of the A-TAC inventory when screening for childhood-onset 
neurodevelopmental problems in a population-based sample. BMC Psychiatry 13, 233 (2013). 
45. Kerekes, N. et al. Oppositional defiant- and conduct disorder-like problems: neurodevelopmental 
predictors and genetic background in boys and girls, in a nationwide twin study. PeerJ 2, e359 
(2014). 
46. Angold, A., Costello, E. J., Messer, S. C., & Pickles, A.  . Development of a short questionnaire for 
use in epidemiological studies of depression in children and adolescents. International Journal of 
Methods in Psychiatric Research 5, 237-249 (1995). 
47. Hale, W.W., 3rd, Raaijmakers, Q., Muris, P. & Meeus, W. Psychometric properties of the Screen 
for Child Anxiety Related Emotional Disorders (SCARED) in the general adolescent population. J 
Am Acad Child Adolesc Psychiatry 44, 283-90 (2005). 
48. Thapar, A. & McGuffin, P. Validity of the shortened Mood and Feelings Questionnaire in a 
community sample of children and adolescents: a preliminary research note. Psychiatry Res 81, 
259-68 (1998). 
49. Rhew, I.C. et al. Criterion validity of the Short Mood and Feelings Questionnaire and one- and 
two-item depression screens in young adolescents. Child Adolesc Psychiatry Ment Health 4, 8 
(2010). 
50. Van Meter, A.R. et al. Diagnostic efficiency of caregiver report on the SCARED for identifying 
youth anxiety disorders in outpatient settings. Journal of Clinical Child & Adolescent Psychology, 
1-15 (2016). 
51. Cosi, S., Canals, J., Hernández-Martinez, C. & Vigil-Colet, A. Parent–child agreement in SCARED 
and its relationship to anxiety symptoms. Journal of Anxiety Disorders 24, 129-133 (2010). 
52. Wolf, E.J., Harrington, K.M., Clark, S.L. & Miller, M.W. Sample Size Requirements for Structural 
Equation Models: An Evaluation of Power, Bias, and Solution Propriety. Educ Psychol Meas 76, 
913-34 (2013). 
53. Dudbridge, F. Power and predictive accuracy of polygenic risk scores. PLoS Genet 9, e1003348 
(2013). 
54. Birmaher, B. et al. Psychometric Properties of the Screen for Child Anxiety Related Emotional 
Disorders (SCARED): A Replication Study. Journal of the American Academy of Child & Adolescent 
Psychiatry 38, 1230-1236 (1999). 
55. Crocetti, E., Hale, W.W., Fermani, A., Raaijmakers, Q. & Meeus, W. Psychometric properties of 
the Screen for Child Anxiety Related Emotional Disorders (SCARED) in the general Italian 
adolescent population: A validation and a comparison between Italy and The Netherlands. 
Journal of Anxiety Disorders 23, 824-829 (2009). 
21 
 
56. Muris, P., Merckelbach, H., Schmidt, H. & Mayer, B. The revised version of the Screen for Child 
Anxiety Related Emotional Disorders (SCARED-R): Factor structure in normal children. Personality 
and Individual Differences 26, 99-112 (1998). 
57. Lahey, B.B., Krueger, R.F., Rathouz, P.J., Waldman, I.D. & Zald, D.H. A hierarchical causal 
taxonomy of psychopathology across the life span. Psychol Bull 143, 142-186 (2017). 
58. Reise, S.P. The Rediscovery of Bifactor Measurement Models. Multivariate Behavioral Research 
47, 667-696 (2012). 
59. Hu, L.t. & Bentler, P.M. Cutoff criteria for fit indexes in covariance structure analysis: 
Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary 
Journal 6, 1-55 (1999). 
60. Muthén, L.K. & Muthén, B.O. Mplus User’s Guide. Seventh Edition., (Muthén & Muthén Los 
Angeles, CA, 1998-2012). 
61. Rodriguez, A., Reise, S.P. & Haviland, M.G. Evaluating bifactor models: Calculating and 
interpreting statistical indices. Psychol Methods 21, 137-50 (2016). 
62. Neumann, A. et al. Single Nucleotide Polymorphism Heritability of a General Psychopathology 
Factor in Children. Journal of the American Academy of Child & Adolescent Psychiatry 55, 1038-
1045.e4 (2016). 
63. Laceulle, O.M., Vollebergh, W.A.M. & Ormel, J. The Structure of Psychopathology in 
Adolescence:Replication of a General Psychopathology Factor in the TRAILS Study. Clinical 
Psychological Science 3, 850-860 (2015). 
64. Staller, J. & Faraone, S.V. Attention-Deficit Hyperactivity Disorder in Girls. CNS Drugs 20, 107-123 
(2006). 
65. Turley, P. et al. MTAG: Multi-Trait Analysis of GWAS. bioRxiv (2017). 
66. Maier, R. et al. Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for 
Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. The American Journal of Human 
Genetics 96, 283-294 (2015). 
67. Porter, H.F. & O’Reilly, P.F. Multiǀariate siŵulatioŶ fraŵeǁork reǀeals perforŵaŶce of ŵulti-trait 
GWAS methods. Scientific Reports 7, 38837 (2017). 
68. Chang, Z., Lichtenstein, P., Asherson, P.J. & Larsson, H. Developmental twin study of attention 
problems: high heritabilities throughout development. JAMA Psychiatry 70, 311-8 (2013). 
69. Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 
schizophrenia-associated genetic loci. Nature 511, 421-427 (2014). 
 
 
  
22 
 
Figure legends 
Figure 1. Path diagram of the general factor model in the A-TAC subsample (A) and 
SMFQ/SCARED subsample (B).  
Legend. 
Path diagram for the general factor models, presented by study subsample. Latent factors are 
depicted as circles. For clarity, covariates (age, sex and the six principal components) and 
correlations across latent trait factors are omitted in the above graphical representation. The models 
consisted of a latent general psychopathology factor (GP) and specific latent trait factors reflecting 
symptoms dimensions of inattention (IA), hyperactivity/impulsivity (H/I), autism spectrum 
disorder (ASD), learning difficulties (LD), oppositional defiant disorder (ODD), conduct disorder 
(CD), depression (DEP), and anxiety (ANX) or panic disorder (PD), generalized anxiety (GAD), 
separation anxiety (SAD), school anxiety (SA), and social phobia (SP). Variances for all latent 
factors were fixed at 1. Measured variables are depicted as squares, and include the ADHD PRS 
and all symptoms items from Autism-Tics, ADHD, and Other Comorbidities inventory (A-TAC), 
the Short Mood and Feelings Questionnaire (SMFQ), and the Screen for Child Anxiety Related 
Emotional Disorders (SCARED). Numbers 1…X indicate the number of symptom items loading 
onto each specific latent trait factor. β1-βx represent the regression coefficients, regressing each 
latent variable onto ADHD PRS. Note that the corresponding path diagrams for the correlated 
factors models are identical, excluding the general psychopathology factor. 
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Table 1. Model fit for the correlated factor model and the general factor model in A-TAC  
subsample and SMFQ/SCARED subsample 
Model CFI RMSEA (90%CI) χ2 (df) Δχ2 diff df p 
A-TAC subsample  
GF 0.97 0.02 (0.02-0.02)  6674.06 (2216) - - - 
CF 0.95  0.02 (0.02–0.02) 8636.54 (2287) 1962.48 71 < .0001 
SMFQ/SCARED subsample  
GF 0.96 0.01 (0.01-0.01)  12544.05 (5275) - - - 
CF 0.94 0.02 (0.02-0.02)  16123.77 (5382) 3579.72 107 < .0001 
 
GF, general factor model. CF, correlated factor model. CFI, comparative fit index (CFI). RMSEA, 
root mean square error of approximation. χ2, chi-square. df, degrees of freedom. The likelihood 
ratio (chi-square) test of model fit was run using the DIFFTEST option in MPlus, comparing the 
fit of the nested correlated factor model to the general factor model. 
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Table 2. Standardized factor loadings from the correlated factor model and the general factor model in A-TAC  
subsample and SMFQ/SCARED subsample 
Scale Item Latent Trait Factor Loadings GP Loadings 
    
Mod1 Mod2 Mod3 Mod4 Mod2 Mod4 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In
at
te
n
tio
n
 
Fails to pay close attention to details? 0.80 0.20 0.77 0.25 0.78 0.73 
Difficulty sustaining attention in tasks? 0.91 0.02† 0.89 0.17 0.90 0.86 
Often does not listen when spoken to directly? 0.86 0.19 0.84 0.30 0.85 0.79 
Difficulty following instructions and finishing tasks? 0.91 -0.13 0.91 0.02† 0.91 0.91 
Difficulty organizing tasks/activities? 0.91 -0.09 0.91 0.06* 0.91 0.91 
Often avoid tasks that require sustained mental effort? 0.84 0.01† 0.80 0.02ƚ 0.83 0.80 
Often loses things? 0.77 0.61 0.78 0.69 0.69 0.62 
Easily distracted/disturbed? 0.89 0.07* 0.87 0.20 0.89 0.84 
Often forgetful in daily activities? 0.79 0.57 0.79 0.64 0.70 0.63 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H
yp
er
a
ct
iv
ity
/Im
pu
lsi
v
ity
 
Difficulties holding hands and feet still, cannot stay 
seated? 
0.81 0.49 0.79 0.43 0.61 0.64 
Often move about in school or in other situations 
when s/he is supposed to remain seated? 
0.84 0.40 0.82 0.37 0.68 0.68 
Often run around and climbs more than his/hers peers? 0.78 0.51 0.73 0.47 0.58 0.56 
Difficulty playing calmly and quietly? 0.88 0.53 0.89 0.45 0.68 0.72 
Often on the go or often act as if driven by a motor? 0.85 0.58 0.85 0.53 0.63 0.65 
Talks excessively? 0.69 0.59 0.65 0.56 0.45 0.43 
Often blurt out answers? 0.74 0.63 0.75 0.59 0.49 0.52 
Difficulty awaiting turns? 0.88 0.63 0.87 0.63 0.62 0.62 
Often interrupt or intrude on others? 0.87 0.66 0.85 0.64 0.60 0.61 
Easily bored? 0.80 0.37 0.79 0.34 0.66 0.66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Language development delayed? 0.45 0.19 0.40 0.05ƚ 0.39 0.40 
 
 
Difficulties sustaining a conversation? 0.75 0.34 0.78 0.39 0.64 0.66 
 
 
Like to repeat words and expressions, use of words in 
a way other people find strange? 
0.74 0.44 0.68 0.35 0.59 0.57 
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Difficulties with pretend play or imitates considerably 
less than other children? 
0.59 0.45 0.64 0.38 0.42 0.51 
 
 
Talk in too high pitch or too quietly? 0.53 0.35 0.53 0.30 0.40 0.42 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
u
tis
m
 
Sp
ec
tr
u
m
 
D
iso
rd
er
 
Difficulties keeping "on track" when telling other 
people something? 
0.80 0.25 0.75 0.10 0.72 0.73 
Difficulties expressing emotions and reactions with 
facial gestures, prosody, or body language? 
0.80 0.56 0.84 0.45 0.59 0.69 
Exhibits considerable difficulties interacting with 
peers? 
0.86 0.64 0.86 0.53 0.62 0.68 
Uninterested in sharing joy, interests, and activities 
with others? 
0.81 0.58 0.70 0.48 0.60 0.53 
Can only be with other people on own terms? 0.78 0.58 0.74 0.46 0.56 0.58 
Difficulties behaving as expected by peers? 0.90 0.58 0.89 0.48 0.69 0.73 
Is s/he easily influenced? 0.77 0.25 0.66 0.22 0.68 0.60 
Absorbed by interests in a repetitive or too intense 
way? 
0.72 0.47 0.68 0.42 0.56 0.54 
Absorbed by routines in a way that produces 
problems? 
0.76 0.59 0.78 0.67 0.54 0.52 
Ever engaged in strange hand movements or walking 
high on tiptoe when s/he was happy or upset? 
0.60 0.44 0.52 0.31 0.45 0.41 
 
 
Gets absorbed by details? 0.78 0.60 0.77 0.62 0.56 0.53 
 
 
Dislikes changes in daily routines? 0.71 0.59 0.74 0.65 0.49 0.50 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Le
a
rn
in
g 
di
ffi
cu
lti
es
 More difficulties than expected acquiring reading 
skills? 
0.74 0.51 0.75 0.50 0.61 0.62 
Is learning slow and laborious? 0.97 0.51 0.96 0.50 0.79 0.77 
Difficulties with basic maths? 0.83 0.48 0.80 0.53 0.68 0.66 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
pp
o
sit
io
n
a
l 
de
fia
n
t d
iso
rd
er
 Ever been so angry that s/he cannot be reached? 0.71 0.52 0.69 0.53 0.48 0.45 
Often argue with adults? 0.84 0.64 0.77 0.62 0.56 0.49 
Often tease others by deliberately doing things that are 
perceived as provocative? 
0.74 0.52 0.73 0.53 0.51 0.50 
Easily offended or disturbed by others? 0.86 0.64 0.84 0.63 0.57 0.56 
Easily teased? 0.84 0.67 0.81 0.61 0.55 0.53 
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A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
o
n
du
ct
 
di
so
rd
er
 
Ever been deliberately physically cruel to anybody? 0.75 0.65 0.72 0.62 0.46 0.44 
Often start fights? 0.79 0.78 0.80 0.72 0.45 0.48 
Often lie or cheat? 0.80 0.48 0.78 0.50 0.56 0.54 
Steal things? 0.85 0.53 0.89 0.59 0.60 0.62 
Ever engaged in shoplifting? 0.46 0.29 0.48 0.36 0.32 0.32 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
ep
re
ss
io
n
  
Poor self-confidence? 0.81 0.61 na  na 0.53 na 
Often complain about bellyaches, headaches, 
breathing difficulties or other bodily symptoms? 
0.56 0.55 na na 0.32 na 
Recurrent periods of obvious irritability? 0.86 0.61 na na 0.58 na 
Self-confidence vary considerably across situations? 0.82 0.64 na na 0.53 na 
Sleeping problems? 0.62 0.53 na na 0.38 na 
A
-
TA
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
n
x
ie
ty
 
 
Difficulty functioning outside the family house? 1.00 0.66 na na 0.61 na 
Often voice fears that family members may die or get 
hurt? 
0.61 0.52 na na 0.32 na 
Unreasonable fear of being alone? 0.68 0.63 na na 0.34 na 
Difficulty sleeping if a family member is not around? 0.63 0.65 na na 0.29 na 
Complain of recurring headaches, bellyaches, nauseas 
or vomits after separation from loved ones? 
0.63 0.73 na na 0.24 na 
Panic attacks? 0.67 0.63 na na 0.33 na 
Fear leaving the house alone, being in crowds/waiting 
in line/ riding bus or train? 
0.73 0.59 na na 0.40 na 
Particularly nervous or anxious? 0.81 0.69 na na 0.44 na 
SM
FQ
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
ep
re
ss
io
n
  
Felt miserable and unhappy? na na 0.72 0.74 na 0.28 
Did not enjoy anything at all? na na 0.64 0.59 na 0.30 
Felt so tired that s/he just sat around and do nothing? na na 0.55 0.44 na 0.31 
Very restless? na na 0.78 0.34 na 0.60 
Felt s/he is no good anymore? na na 0.84 0.81 na 0.34 
Cried a lot? na na 0.74 0.76 na 0.28 
Found it hard to think properly or concentrate? na na 0.90 0.44 na 0.66 
Hated him/herself? na na 0.85 0.80 na 0.36 
Felt s/he was a bad person? na na 0.86 0.83 na 0.33 
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Felt lonely? na na 0.77 0.69 na 0.38 
Felt unloved? na na 0.85 0.78 na 0.38 
Thought s/he could never be as good as other kids? na na 0.84 0.76 na 0.40 
Thought s/he did everything wrong? na na 0.85 0.80 na 0.37 
SC
A
R
ED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pa
ni
c 
di
so
rd
er
 
When frightened, s/he has difficulties breathing. na na 0.73 0.72 na 0.26 
When frightened, s/he feels like passing out. na na 0.67 0.71 na 0.19 
When frightened, s/he feels like s/he is going crazy.  na na 0.92 0.66 na 0.51 
When frightened, s/he feels like things are not real. na na 0.75 0.65 na 0.34 
When frightened, her/his heart beats fast. na na 0.56 0.51 na 0.23 
Really frightened for no reason at all.  na na 0.59 0.58 na 0.21 
When frightened, s/he feels like throwing up.  na na 0.88 0.83 na 0.34 
When frightened, s/he feels dizzy. na na 0.67 0.66 na 0.24 
S/he gets shaky.  na na 0.71 0.75 na 0.21 
SC
A
R
ED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G
en
er
a
liz
ed
 a
nx
ie
ty
 d
iso
rd
er
  
Worries about other people liking him/her.  na na 0.75 0.66 na 0.35 
Worries about being as good as other kids.  na na 0.77 0.72 na 0.32 
Worries about what is going to happen in the future.  na na 0.79 0.75 na 0.32 
Worries about how well s/he does things.  na na 0.82 0.76 na 0.34 
Worries about things that have already happened.  na na 0.76 0.63 na 0.39 
My child is nervous.  na na 0.89 0.68 na 0.51 
Worries about things working out for him/her.  na na 0.82 0.78 na 0.33 
Told s/he worries too much.  na na 0.78 0.74 na 0.32 
 My child is a worrier.  na na 0.82 0.81 na 0.30 
SC
A
R
ED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Se
pa
ra
tio
n
 a
n
x
ie
ty
  
Scared sleeping away from home.  na na 0.64 0.65 na 0.18 
My child follows me wherever I go.  na na 0.83 0.54 na 0.46 
Worries about sleeping alone. na na 0.70 0.63 na 0.26 
Nightmares something bad will happen to her/his 
parents.  
na na 0.78 0.78 na 0.23 
Nightmares something bad will happen to him/her.  na na 0.68 0.68 na 0.21 
Afraid to be alone in the house.  na na 0.60 0.58 na 0.19 
Doesn’t like to be away from family. na na 0.64 0.66 na 0.17 
Worries that something bad might happen to parents. na na 0.83 0.80 na 0.26 
28 
 
SC
A
R
ED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sc
ho
ol
 
a
n
x
ie
ty
  Headaches when s/he is at school.  na na 0.58 0.50 na 0.29 
Stomachaches at school.  na na 0.81 0.79 na 0.34 
Worries about going to school.  na na 0.95 0.84 na 0.46 
Scared to go to school. na na 0.98 0.85 na 0.49 
SC
A
R
ED
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
So
ci
a
l p
ho
bi
a
 
Doesn’t like to be with people s/he doesn’t know well.  na na 0.82 0.77 na 0.26 
Nervous with people s/he doesn’t know well.  na na 0.90 0.82 na 0.33 
Hard to talk with people s/he doesn’t know well.  na na 0.87 0.86 na 0.23 
Shy with people s/he doesn’t know well.  na na 0.84 0.90 na 0.09 
Nervous if s/he has do something while others watch. na na 0.77 0.61 na 0.37 
Nervous when s/he is going to a place where there will 
be people that s/he doesn’t know well.  
na na 0.83 0.74 na 0.32 
My child is shy.  na na 0.81 0.85 na 0.09 
 
Mod1: Correlated factor model in A-TAC subsample.  
Mod2: General factor model in A-TAC subsample.  
Mod3: Correlated factor model in SMFQ/SCARED subsample.  
Mod4: General factor model in SMFQ/SCARED subsample.  
 
Note: GP loadings, loading onto the general psychopathology factor for all items. Latent trait factor loadings, loadings onto each latent 
trait factor corresponding to the specific item scales of A-TAC, SMFQ and SCARED. † Not significant at p≤0.05; * Significant at 
p≤0.001. All other estimates significant at p≤0.0001. Four items from the PD scale had to be excluded from the model due very few 
endorsements, leading to estimation problems of the polychoric correlations. The items were “People tell to my child that s/he looks 
nervous”, “When my child gets frightened, s/he sweats a lot”, “When my child gets frightened, s/he feels like s/he is choking”,  and “My 
child is afraid of having anxiety (or panic) attacks”
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Table 3. Association between ADHD PRS and latent trait factors in the correlated  
factor model and the general factor model (PRS p-value threshold < 0.5) 
 
  Correlated factors model   General factor model 
Latent 
Factor Beta S.E p R2 
 
Beta S.E p R2 
A-TAC subsample  (N= 6603) 
GP na na na na 
 
0.09 0.02 <.0001 0.86% 
IA 0.09 0.02 <.0001 0.83% 
 
-0.01 0.02 0.929 0.00% 
H/I 0.11 0.02 <.0001 1.19% 
 
0.06 0.02 0.003 0.37% 
ASD 0.07 0.02 <.0001 0.50% 
 
-0.01 0.03 0.862 0.00% 
LD 0.07 0.02 <.0001 0.53% 
 
-0.01 0.03 0.873 0.00% 
ODD 0.06 0.02 <.001 0.41% 
 
0.01 0.02 0.895 0.00% 
CD 0.08 0.03 0.007 0.69% 
 
0.03 0.04 0.390 0.12% 
DEP 0.05 0.02 0.009 0.26% 
 
-0.01 0.02 0.564 0.01% 
ANX 0.05 0.02 0.053 0.22% 
 
0.00 0.03 0.998 0.00% 
SCARED/SMFQ Subsample (N=6854) 
GP na na na na 
 
0.10 0.02 <.0001 1.06% 
IA 0.10 0.02 <.0001 1.08% 
 
0.02 0.02 0.482 0.02% 
H/I 0.13 0.02 <.0001 1.69% 
 
0.08 0.02 <.0001 0.69% 
ASD 0.06 0.02 0.001 0.40% 
 
-0.03 0.02 0.220 0.08% 
LD 0.07 0.02 0.002 0.45% 
 
-0.03 0.03 0.308 0.08% 
ODD 0.10 0.02 <.0001 0.98% 
 
0.04 0.02 0.058 0.17% 
CD 0.11 0.03 <.0001 1.19% 
 
0.05 0.03 0.117 0.26% 
DEP 0.07 0.02 <.001 0.42% 
 
0.02 0.02 0.411 0.03% 
PD 0.06 0.03 0.014 0.41% 
 
0.02 0.03 0.405 0.05% 
GAD 0.03 0.02 0.066 0.10% 
 
-0.01 0.02 0.450 0.02% 
SAD 0.01 0.02 0.826 0.00% 
 
-0.03 0.02 0.071 0.10% 
SA 0.00 0.03 0.996 0.00% 
 
-0.05 0.03 0.052 0.27% 
SP -0.02 0.02 0.272 0.04% 
 
-0.05 0.02 0.004 0.24% 
 
All models were adjusted for sex, age and six principal components. Reported betas are 
standardized. S.E, standard error. R2, variance explained (beta2).  Significant estimates are in bold. 
Results from the correlated factor model reflect associations between ADHD PRS prior to 
accounting for covariance across all symptoms via the general psychopathology factor. GP, general 
psychopathology. IA, inattention. H/I, hyperactivity/impulsivity. ASD, autism spectrum disorder. 
LD, learning difficulties. ODD, oppositional defiant disorder. CD, conduct disorder. DEP, 
depression. ANX, anxiety. PD, panic disorder. GAD, generalized anxiety disorder. SAD, 
separation anxiety disorder. SA, school anxiety. SP, social phobia. 
 
